Erlotinib-induced hair repigmentation

International Journal of Dermatology

Volumn 53, Issue 1, 2014, Pages

  Cheng, Yu Pin ^a   Chen, Hsiang Jung ^a,b   Chiu, Hsien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; IMATINIB; RETINOID;

AGED; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; FEMALE; FOLLICULITIS; HAIR DISCOLORATION; HUMAN; LETTER; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; PARONYCHIA; PYOGENIC GRANULOMA; SCALP HAIR; TREATMENT DURATION; TREATMENT OUTCOME; XEROSIS;

ADENOCARCINOMA; AGED; FEMALE; HAIR COLOR; HUMANS; LUNG NEOPLASMS; PIGMENTATION; PROTEIN KINASE INHIBITORS; QUINAZOLINES;

EID: 84890791921     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05422.x     Document Type: Letter

References (9)

1. Vergou T, Stratigos AJ, Karapanagiotou EM, et al. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib. J Am Acad Dermatol 2010; 63: e56-58.
2. Alexandrescu DT, Kauffman CL, Dasanu CA. Persistent hair growth during treatment with the EGFR inhibitor erlotinib. Dermatol Online J 2009; 15: 4.
3. Etienne G, Cony-Makhoul P, Mahon FX. Imatinib mesylate and gray hair. N Engl J Med 2002; 347: 446.
4. Seckin D, Yildiz A. Repigmentation and curling of hair after acitretin therapy. Australas J Dermatol 2009; 50: 214-216.
5. Kourelis K, Vandoros G, Kourelis T, et al. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation. J Otolaryngol Head Neck Surg 2009; 38: 233-239.
6. Mitchell EP, Perez-Soler R, Van Cutsem E, et al. Clinical presentation and pathophysiology of EGFRI dermatologic toxicities. Oncology (Williston Park) 2007; 21: 4-9.
7. Shaffrali FC, McDonagh AJ, Messenger AG. Hair darkening in porphyria cutanea tarda. Br J Dermatol 2002; 146: 325-329.
8. Pongpudpunth M, Demierre MF, Goldberg LJ. A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib. J Cutan Pathol 2009; 36: 1303-1307.
9. Hoekzema R, Drillenburg P. Folliculitis decalvans associated with erlotinib. Clin Exp Dermatol 2010; 35: 916-918.